Health care stocks stumble with broader market
(01-20) 13:06 PST INDIANAPOLIS, (AP) –
Health care shares slipped Wednesday on anxiety over the challenges that lie ahead careless of whether a health care overhaul materializes in Washington.
Get Quote
Symbol Lookup
More Business
New York Times, Coach, Kraft Foods, CSX are movers 01.20.10
Maine lawmakers take by ~t saltwater license mandate 01.20.10
Stocks fall as China clamps downward on bank lending 01.20.10
Wash. state jobless rate jumps to 9.5 percent 01.20.10
The least bit followed an earlier surge for several pharmaceutical and managed care companies, being of the kind which investors anticipated either a Republican victory in the race for a Massachusetts Senate abode or a close vote that could derail the health care look into push.
Republican Scott Brown upset Democrat Martha Coakley Tuesday to take the recently deceased Edward M. Kennedy’s seat.
His surprise victory cast doubt put ~ the future of President Obama’s health care initiative as Democrats resoluteness no longer have a 60-vote Senate majority. That number is clew because it would have allowed Democrats a better shot and transient a law that would have provided coverage for millions of men who currently have none.
Investors had worried for months about the stroke this reform push might have on health care businesses. Insurers, by reason of instance, will be subjected to taxes, fees and increased regulation below the proposed measure.
Even though the shape of the nation’s freedom from disease care system appears more blurry than it did at the fit of the week, many health care companies that might benefit from a stalled statement of particulars dropped slightly Wednesday afternoon along with the broader market. The Standard & Poor’s 500 pointer fell 1.4 percent.
Shares of managed care company UnitedHealth Group Inc. cut down 58 cents, or 1.6 percent, to $34.55; drugmaker Eli Lilly and Co. dropped 11 cents, or 0.29 percent, to $37.30, and underwriter Humana Inc. fell 67 cents, or 1.3 percent, to $51.27.
Analysts yet believe that drug companies and health insurers face daunting problems. Drug companies, conducive to instance, have struggled to develop new medications on their own, and patents protecting single multibillion dollar drugs will expire in the next few years.
Health insurers are after that dealing with enrollment losses caused by high unemployment. Medicare Advantage repayment cuts will squeeze profits for some companies, said Edward Jones algebraist Steve Shubitz.
“The operating environment in 2010 is going to exist challenging,” he said.
Aetna Inc. and UnitedHealth Group Inc. both be favored with said they expect their 2010 operating earnings — which exclude single in kind-time items like investment income — to be lower than ultimate year.
Many stocks have seen strong rallies over the past small in number weeks, and some investors likely sold Wednesday to take a gain advantage, BMO Capital Markets analyst Dave Shove said. He noted that UnitedHealth and WellPoint shares be in possession of risen 15 percent and 17 percent, respectively, since the start of 2010.
“There’s to all appearance a little bit of earnings nervousness in here now too,” he said. “In a sense, now we have to get back to fundamentals.”
UnitedHealth reports earnings Thursday. That stock is considered a bellwether for the sector, and its play can influence the shares of other insurers. Analysts who’ve seen decent gains from other health insurance stocks may be tempted to barter in case UnitedHealth offers disappointing guidance for the year ahead, Shove reported.
On top of these concerns, Bannister also noted that the hale condition care fight isn’t over.
“Even if we don’t achieve legislation today, you can’t say, ‘Well gosh we’re in no degree gonna get legislation,’” she said. “We still have an issue in this countrified with access and cost and quality, so those fundamental issues exigency to be addressed.”